Wen, P. Y., Iwamoto, F. M., Kotecha, R., Yurasov, S., Hajdenberg, J., Puduvalli, V. K. (2026). Randomized phase 2 study to evaluate the efficacy and safety of silevertinib in combination with temozolomide in newly diagnosed patients with EGFRvIII-positive IDHwt MGMT unmethylated glioblastoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2098